Delivery Order SPE2DB22D1103-SPE2DB25F1634
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,757.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes treatment medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a contract value of $3,903.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity, a diabetes...
- The Defense Logistics Agency awarded a $6,044.85 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,369.73 delivery order for Trulicity 3 mg/0.5 mL pens on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract was executed with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, consistent with AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,229.08 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded a delivery order valued at $1,635.36 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25F1634Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens valued at $3,001.05 on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied through federal medical procurement channels. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor for DLA's medical supply chain, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities worldwide. The company's federal contract performance demonstrates consistent capability to meet competitive procurement requirements across diverse therapeutic domains through firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/8/25 |